On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Insulet saw strong insulin pump adoption among new users with Type 2 diabetes following its recent FDA clearance, while ...

Tandem Diabetes Care (NASDAQ:TNDM – Free Report) had its target price boosted by Barclays from $58.00 to $60.00 in a research ...

Tandem Diabetes Care shares ticked up after hours today on third-quarter results that topped the consensus forecast.

The pumps themselves generate just over half ... Unraveling the Financial Story of Tandem Diabetes Care Market Capitalization Analysis: The company's market capitalization is above the industry ...

and Tandem Mobi insulin pump, an automated insulin delivery system. Receive News & Ratings for Tandem Diabetes Care Daily - ...

While the top- and bottom-line numbers for Tandem Diabetes Care (TNDM) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key ...

Tandem Diabetes Care reported a strong second quarter in 2024, outperforming expectations in both sales and EBITDA. This impressive performance was largely attributed to the successful launch of the ...

slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Tandem Diabetes Care is based in San Diego, California. For more information, visit tandemdiabetes.com.

Tandem Diabetes Care Inc (TNDM) achieves highest quarterly sales in history, driven by strong US and international growth, ...

Welcome to the Tandem Diabetes Care Q3 2024 Earnings Conference ... particularly in the primary care channel, onto pumps? Thanks. I think it's both. I think when you get to the physician, I ...

The pumps themselves generate just over half ... Positive Revenue Trend: Examining Tandem Diabetes Care's financials over 3 months reveals a positive narrative. The company achieved a noteworthy ...